Add Formweb to your mobile device
Search results for:
morphine
morphine
| Drug Name | Form | Strength | Notes |
|---|---|---|---|
| Kadian | CAPSULE, EXTENDED RELEASE, ORAL | 10 mg/24 hr | |
| Kadian | CAPSULE, EXTENDED RELEASE, ORAL | 20 mg/24 hr | |
| AVINza | CAPSULE, EXTENDED RELEASE, ORAL | 30 mg/24 hours | |
| Morphine Sulfate ER | CAPSULE, EXTENDED RELEASE, ORAL | 30 mg/24 hours | |
| AVINza | CAPSULE, EXTENDED RELEASE, ORAL | 45 mg/24 hours | |
| Kadian | CAPSULE, EXTENDED RELEASE, ORAL | 50 mg/24 hours | |
| AVINza | CAPSULE, EXTENDED RELEASE, ORAL | 60 mg/24 hours | |
| AVINza | CAPSULE, EXTENDED RELEASE, ORAL | 90 mg/24 hours | |
| AVINza | CAPSULE, EXTENDED RELEASE, ORAL | 120 mg/24 hours | |
| Morphine Sulfate | CONCENTRATE, ORAL | 20 mg/mL | |
| Astramorph PF | SOLUTION, INJECTABLE | 0.5 mg/mL PF | |
| Duramorph PF | SOLUTION, INJECTABLE | 0.5 mg/mL preservative-free | |
| Astramorph PF | SOLUTION, INJECTABLE | 1 mg/mL PF | |
| Duramorph PF | SOLUTION, INJECTABLE | 1 mg/mL preservative-free | |
| Morphine Sulfate | SOLUTION, INJECTABLE | 2 mg/mL | |
| Morphine Sulfate | SOLUTION, INJECTABLE | 4 mg/mL | |
| Morphine Sulfate | SOLUTION, INJECTABLE | 5 mg/mL | |
| Morphine Sulfate | SOLUTION, INJECTABLE | 10 mg/mL | |
| Morphine Sulfate | SOLUTION, INJECTABLE | 15 mg/mL | |
| Morphine Sulfate | SOLUTION, INJECTABLE | 25 mg/mL preservative-free | |
| Morphine Sulfate | SOLUTION, INJECTABLE | 50 mg/mL | |
| Morphine Sulfate | SOLUTION, INTRAVENOUS | 1 mg/mL-NaCl 0.9% | |
| Morphine Sulfate | SOLUTION, INTRAVENOUS | 2 mg/mL-NaCl 0.9% | |
| Morphine Sulfate | SOLUTION, ORAL | 10 mg/5 mL | |
| Morphine Sulfate | SOLUTION, ORAL | 20 mg/5 mL | |
| Morphine Sulfate | SUPPOSITORY, RECTAL | 10 mg | |
| Morphine Sulfate ER | TABLET, EXTENDED RELEASE, ORAL | 15 mg/12 hr | |
| Morphine Sulfate ER | TABLET, EXTENDED RELEASE, ORAL | 30 mg/12 hr | |
| Morphine Sulfate ER | TABLET, EXTENDED RELEASE, ORAL | 60 mg/12 hours | |
| Morphine Sulfate ER | TABLET, EXTENDED RELEASE, ORAL | 100 mg/12 hours | |
| Morphine Sulfate ER | TABLET, EXTENDED RELEASE, ORAL | 200 mg/12 hours | |
| Morphine Sulfate | TABLET, ORAL | 15 mg | |
| Morphine Sulfate | TABLET, ORAL | 30 mg | |
| MS Contin | |||
| Roxanol |
Last updated: Apr. 28, 2026
- High Alert: CAUTION: See High-Alert Medication Policy
- RCRA: Disposal
- RCRA: Management of Pharmaceutical Waste Policy
- Do Not Crush: Enteric Coated/ER Capsule
- Black Box Warning: 24-hour observation following epidural/intrathecal administration
- REMS: Opioid Analgesic REMS-FDA REMS Info
- REMS: Legacy Health REMS Requirements-Opioid Analgesics
Class II
morphine
Patient Controlled Analgesia (PCA): See Policy 900.4103
Use of oral morphine solution in Neonatal Opioid Withdrawal Syndrome (NOWS): See Protocol 911.5076
Morphine sulphate may be given via hypodermoclysis (HDC/subcutaneous infusion). See Procedure 904.4991
Use in mechanically ventilated patients, See the Pain, Agitation and Delirium Protocol (aka "PAD") Protocol 901.6008
For pediatric long term sedation weaning: See Protocol 912.6016
Administration of concentrated oral 20mg/1ml morphine solution (ROXANOL): See Tip Sheet on Sublingual (SL) Administration
Infusion Concentrations and Ranges:
Adult General Titration Ranges and Administration (weight based dosing): See Handout (updated Aug 2016)
The Opioid Analgesic REMS program includes health care provider and patient related requirements for prescribing, see Legacy Health REMS Requirements for detail.